Superoxide dismutase decreases reperfusion arrhythmias and preserves myocardial function during thrombolysis with tissue plasminogen activator.

J. L. Mehta,W. W. Nichols,Tom Saldeen,V. K. Chandna,F.A. Nicolini,Daniel Lawson,M. F. Ter Riet

Superoxide dismutase decreases reperfusion arrhythmias and preserves myocardial function during thrombolysis with tissue plasminogen activator.

1990

J. L. Mehta
W. W. Nichols
Tom Saldeen
V. K. Chandna
F.A. Nicolini
Daniel Lawson
M. F. Ter Riet

Comparison of the effects of thrombolytic therapy with tissue plasminogen activator alone or in combination with recombinant superoxide dismutase in a canine model of coronary thrombosis.

Keywords:

Cardiology
Thrombolysis
Superoxide dismutase
Fissipedia
Coronary thrombosis
Thrombosis
Vascular disease
Tissue plasminogen activator
Chemotherapy
Medicine
Internal medicine
Ventricular fibrillation
Hemodynamics

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations